STRS Ohio’s Replimune Group REPL Stock Holding History

STRS Ohio’s Portfolio REPL Stock Details REPL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-4,300	Closed	-$75K	–	2071
2023 Q1	$75K	Hold	4,300	–	–	﹤0.01%	1743
2022 Q4	$116K	Hold	4,300	–	–	﹤0.01%	1707
2022 Q3	$74K	Hold	4,300	–	–	﹤0.01%	1784
2022 Q2	$75K	Hold	4,300	–	–	﹤0.01%	1808
2022 Q1	$73K	Hold	4,300	–	–	﹤0.01%	1898
2021 Q4	$116K	Hold	4,300	–	–	﹤0.01%	1871
2021 Q3	$127K	Sell	4,300 -2,200	-34%	-$71.4K	﹤0.01%	1894
2021 Q2	$249K	Buy	6,500 +600	+10%	+$20.5K	﹤0.01%	1755
2021 Q1	$180K	Sell	5,900 -800	-12%	-$30K	﹤0.01%	1815
2020 Q4	$255K	Buy	6,700 +4,000	+148%	+$167K	﹤0.01%	1691
2020 Q3	$62K	Hold	2,700	–	–	﹤0.01%	1934
2020 Q2	$67K	Buy	2,700 +600	+29%	+$10.6K	﹤0.01%	1863
2020 Q1	$20K	Hold	2,100	–	–	﹤0.01%	1907
2019 Q4	$30K	Hold	2,100	–	–	﹤0.01%	1950
2019 Q3	$29K	Hold	2,100	–	–	﹤0.01%	1949
2019 Q2	$30K	Hold	2,100	–	–	﹤0.01%	1987
2019 Q1	$31K	Hold	2,100	–	–	﹤0.01%	1934
2018 Q4	$21K	Hold	2,100	–	–	﹤0.01%	1985
2018 Q3	$33K	Buy	+2,100	New	+$36.8K	﹤0.01%	1994

Other funds holding REPL

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

STRS Ohio's REPL Position: Q2 2023 in Review

STRS Ohio sold out of Replimune Group (REPL) in Q2 2023, closing a stake of 4,300 shares — an estimated $75K sold.

STRS Ohio first reported a position in REPL in Q3 2018 and held it in 19 quarters. The position peaked at $255K in Q4 2020. 141 funds tracked by Wall St. Rank hold REPL as of Q2 2023.

STRS Ohio reported no remaining Replimune Group position as of Q2 2023 after selling out during the quarter.
STRS Ohio sold 4,300 Replimune Group shares in Q2 2023, an estimated $75K.
STRS Ohio first reported a position in Replimune Group in Q3 2018 and held it in 19 quarters.
STRS Ohio's Replimune Group position peaked at $255K in Q4 2020.
141 funds tracked by Wall St. Rank held Replimune Group as of Q2 2023.

Based on STRS Ohio's 13F filing for Q2 2023, filed 31 Jul 2023.